- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Apollo Hospitals Chennai Performs India’s First Adaptive Deep Brain Stimulation for Parkinson's - Video
Overview
In a significant step forward for Parkinson’s care in India, Apollo Hospitals Chennai has successfully carried out the country’s first clinical activation of Adaptive Deep Brain Stimulation (aDBS). The procedure, performed in March 2026 by a specialised team led by Dr. Vijayashankar Paramanandam and Dr. Arvind Sukumaran, marks a major advancement in treating movement disorders.
Unlike conventional Deep Brain Stimulation, which delivers constant electrical signals, aDBS adjusts stimulation in real time based on the patient’s brain activity, offering a more personalised and responsive treatment approach.
This breakthrough comes amid a rising burden of Parkinson’s disease, with millions expected to be affected in India in the coming decades. Early results from the treated patient show improved stability and better symptom control throughout the day. Experts believe such technology could significantly improve quality of life, especially for patients with fluctuating symptoms, according to the press release.
The milestone highlights India’s growing adoption of advanced, brain-sensing therapies and reinforces the need for early diagnosis and access to specialised care.


